CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV)
Every FINRA and SEC series the site collects for CLOVER HEALTH INVESTMENTS, CORP. /DE: short interest with days to cover, daily short sale volume, fails to deliver and Form 4 insider trades. Listed on Nasdaq, classified by the SEC as hospital & medical service plans.
26.1M
Short interest
settlement 2026-08-14
5.0
Days to cover
-7.4% vs prior
39.4%
Short share of volume
2026-09-11
2,616
Fails to deliver
settlement 2026-08-14
-$1.3M
Insider flow, 90 days
0 buys, 10 sells
As of 2026-09-11.
Short interest
FINRA, twice a month; the last 12 months shown, all 48 settlements in the JSONAs of 14 August 2026, short interest in CLOV is 26,142,886 shares, down 2,605,997 shares over the last month. Over the last 48 readings it ranged from 11,895,643 shares (28 February 2025) to 54,071,005 shares (15 October 2025). At the reported average volume of 5.2M shares a day that is 5.0 days to cover.
Embed this chartfree, with the attribution line it carries
<iframe src="https://xoomar.com/embed/stocks/clov" width="100%" height="440" style="border:0;max-width:100%" loading="lazy" title="XOOMAR chart"></iframe>
| Settlement | Shares short | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|
| 2026-08-14 | 26,142,886 | -7.4% | 5,247,010 | 4.98 |
| 2026-07-31 | 28,237,098 | -1.8% | 3,932,455 | 7.18 |
| 2026-07-15 | 28,748,883 | +29.6% | 5,876,749 | 4.89 |
| 2026-06-30 | 22,184,648 | -10.7% | 7,916,464 | 2.80 |
| 2026-06-15 | 24,851,129 | -13.1% | 9,964,417 | 2.49 |
| 2026-05-29 | 28,596,652 | -23.5% | 8,252,151 | 3.47 |
| 2026-05-15 | 37,391,816 | -4.3% | 8,128,046 | 4.60 |
| 2026-04-30 | 39,092,575 | -3.7% | 6,110,277 | 6.40 |
| 2026-04-15 | 40,584,684 | +3.7% | 5,292,183 | 7.67 |
| 2026-03-31 | 39,120,656 | +2.0% | 5,959,741 | 6.56 |
| 2026-03-13 | 38,353,703 | -0.3% | 5,132,438 | 7.47 |
| 2026-02-27 | 38,465,992 | -6.4% | 4,957,104 | 7.76 |
| 2026-02-13 | 41,094,460 | +4.9% | 6,435,816 | 6.39 |
| 2026-01-30 | 39,183,403 | -2.5% | 6,633,106 | 5.91 |
| 2026-01-15 | 40,185,802 | +5.3% | 5,750,003 | 6.99 |
| 2025-12-31 | 38,170,121 | -4.4% | 4,173,677 | 9.15 |
| 2025-12-15 | 39,929,930 | -2.3% | 3,965,754 | 10.07 |
| 2025-11-28 | 40,852,910 | -6.0% | 4,979,039 | 8.20 |
| 2025-11-14 | 43,475,437 | +0.9% | 10,319,074 | 4.21 |
| 2025-10-31 | 43,089,212 | -20.3% | 11,515,668 | 3.74 |
| 2025-10-15 | 54,071,005 | +4.5% | 15,140,244 | 3.57 |
| 2025-09-30 | 51,735,259 | +5.0% | 5,129,378 | 10.09 |
| 2025-09-15 | 49,278,776 | +2.0% | 5,450,419 | 9.04 |
| 2025-08-29 | 48,326,485 | -3.9% | 4,390,454 | 11.01 |
Daily short volume
FINRA Reg SHO, last 60 sessions. JSONAs of 11 September 2026, the short share of CLOV volume is 39.4%, up 3.8 points over the last five sessions. Over the last 52 readings it ranged from 22.2% (13 August 2026) to 51.7% (14 July 2026). The latest reading is 4.7 points above the 30-session average of 34.6%, on 2.0M shares reported.
| Date | Short volume | Total volume | Short share | Exempt |
|---|---|---|---|---|
| 2026-09-11 | 779K | 2.0M | 39.4% | 2,824 |
| 2026-09-10 | 1.5M | 3.4M | 45.1% | 217,756 |
| 2026-09-09 | 786K | 1.9M | 40.9% | 7,033 |
| 2026-09-08 | 341K | 1.4M | 24.8% | 8,895 |
| 2026-09-04 | 391K | 892K | 43.9% | 1,800 |
| 2026-09-03 | 394K | 1.1M | 35.6% | 3,157 |
| 2026-09-02 | 459K | 1.5M | 30.1% | 302 |
| 2026-09-01 | 430K | 1.7M | 25.4% | 587 |
| 2026-08-31 | 466K | 1.3M | 34.8% | 937 |
| 2026-08-28 | 487K | 1.9M | 25.3% | 525 |
| 2026-08-27 | 490K | 1.7M | 29.1% | 618 |
| 2026-08-26 | 498K | 1.5M | 33.9% | 1,419 |
| 2026-08-25 | 493K | 1.3M | 38.5% | 11,319 |
| 2026-08-24 | 511K | 1.3M | 39.3% | 25 |
| 2026-08-21 | 393K | 1.4M | 29.0% | 2 |
| 2026-08-20 | 502K | 1.3M | 38.2% | 305 |
| 2026-08-19 | 599K | 1.5M | 38.9% | 5,821 |
| 2026-08-18 | 410K | 1.2M | 35.2% | 814 |
| 2026-08-17 | 1.2M | 2.7M | 43.7% | 91,252 |
| 2026-08-14 | 516K | 1.7M | 30.2% | 185 |
| 2026-08-13 | 395K | 1.8M | 22.2% | 3,001 |
| 2026-08-12 | 605K | 2.4M | 25.5% | 1,578 |
| 2026-08-11 | 577K | 1.9M | 30.0% | 18,611 |
| 2026-08-10 | 693K | 2.3M | 29.8% | 5,698 |
| 2026-08-07 | 749K | 2.4M | 31.4% | 132,939 |
| 2026-08-06 | 1.2M | 4.7M | 25.6% | 4,643 |
| 2026-08-05 | 680K | 1.5M | 44.0% | 0 |
| 2026-08-04 | 760K | 1.5M | 50.2% | 135 |
| 2026-08-03 | 528K | 1.3M | 40.1% | 2,258 |
| 2026-07-31 | 455K | 1.2M | 37.8% | 2,384 |
Fails to deliver
SEC, by settlement date. JSONAs of 14 August 2026, the fails-to-deliver balance in CLOV is 2,616 shares, down 7,384 shares over the last settlement date. Over the last 52 readings it ranged from 5 shares (24 April 2026) to 185,790 shares (30 March 2026). The latest reading sits at the bottom of that range.
| Settlement | Shares failed | Price | Value |
|---|---|---|---|
| 2026-08-14 | 2,616 | $4.49 | $12K |
| 2026-08-10 | 10,000 | $4.76 | $48K |
| 2026-08-07 | 4,807 | $4.66 | $22K |
| 2026-08-04 | 5,364 | $4.33 | $23K |
| 2026-07-30 | 652 | $4.23 | $3K |
| 2026-07-20 | 8,209 | $4.62 | $38K |
| 2026-07-17 | 10,040 | $4.40 | $44K |
| 2026-07-13 | 10,500 | $4.44 | $47K |
| 2026-07-02 | 6,339 | $5.39 | $34K |
| 2026-07-01 | 335 | $5.24 | $2K |
| 2026-06-30 | 17,921 | $5.31 | $95K |
| 2026-06-24 | 313 | $5.06 | $2K |
| 2026-06-22 | 49,543 | $5.00 | $248K |
| 2026-06-17 | 500 | $4.94 | $2K |
| 2026-06-15 | 10,146 | $4.73 | $48K |
| 2026-06-10 | 699 | $4.29 | $3K |
| 2026-06-09 | 49,130 | $3.92 | $193K |
| 2026-06-08 | 8,008 | $3.83 | $31K |
| 2026-06-03 | 18,274 | $3.73 | $68K |
| 2026-06-01 | 500 | $3.98 | $2K |
| 2026-04-24 | 5 | $2.40 | $12 |
| 2026-04-23 | 70 | $2.50 | $175 |
| 2026-04-22 | 1,500 | $2.39 | $4K |
| 2026-04-10 | 21,132 | $1.91 | $40K |
| 2026-04-07 | 42 | $1.87 | $79 |
| 2026-04-06 | 500 | $1.72 | $860 |
| 2026-04-02 | 124,018 | $1.70 | $211K |
| 2026-03-30 | 185,790 | $1.75 | $325K |
| 2026-03-26 | 258 | $1.82 | $470 |
| 2026-03-23 | 86,621 | $1.89 | $164K |
Insider trades
SEC Form 4, newest first, 50 of 100 shown. JSONInsiders at CLOV reported 10 open-market sells worth $1.3M in the last 90 days and no open-market buys. Sells alone are a weak signal; insiders sell for tax, diversification and estate reasons all the time. Latest filing: THORNTON JOSEPH CLAY (Interim CFO) on 2026-08-17.
| Date | Insider | Title | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|---|
| 2026-08-17 | THORNTON JOSEPH CLAY | Interim CFO | Sell | 18K | $4.39 | $78K | 1.2M |
| 2026-08-12 | Soares Karen | Chief Legal Officer | Grant | 109K | $0.00 | $0 | 1.6M |
| 2026-08-12 | THORNTON JOSEPH CLAY | Interim CFO | Grant | 54K | $0.00 | $0 | 1.3M |
| 2026-08-10 | Toy Andrew | Chief Executive Officer | Sell | 88K | $4.65 | $408K | 9.5M |
| 2026-07-20 | Soares Karen | Chief Legal Officer | Sell | 52K | $4.51 | $233K | 1.5M |
| 2026-07-17 | Reynoso Jamie L. | CEO, Medicare Advantage | Sell | 5K | $4.53 | $22K | 2.8M |
| 2026-07-15 | Toy Andrew | Chief Executive Officer | Sell | 63K | $4.67 | $293K | 9.5M |
| 2026-07-15 | Wai Conrad | CEO, Counterpart Health | Sell | 24K | $4.67 | $113K | 1.1M |
| 2026-07-15 | Reynoso Jamie L. | CEO, Medicare Advantage | Sell | 13K | $4.67 | $61K | 2.8M |
| 2026-07-15 | Soares Karen | Chief Legal Officer | Sell | 11K | $4.67 | $49K | 1.6M |
| 2026-07-15 | THORNTON JOSEPH CLAY | Interim CFO | Sell | 5K | $4.67 | $22K | 1.2M |
| 2026-07-08 | Reynoso Jamie L. | CEO, Medicare Advantage | Sell | 2K | $4.68 | $11K | 2.8M |
| 2026-06-11 | Reynoso Jamie L. | CEO, Medicare Advantage | Sell | 7K | $4.91 | $36K | 2.8M |
| 2026-05-28 | Wai Conrad | CEO, Counterpart Health | Sell | 220K | $3.99 | $879K | 1.4M |
| 2026-05-18 | Edwards Carladenise Armbrister | n/a | Sell | 67K | $3.42 | $230K | 285K |
| 2026-05-16 | THORNTON JOSEPH CLAY | Interim CFO | Tax withholding | 17K | $3.47 | $59K | 1.2M |
| 2026-05-13 | Priest Brady Patrick | CEO of Clover Care Services | Sell | 98K | $3.52 | $345K | 2.0M |
| 2026-05-08 | Toy Andrew | Chief Executive Officer | Tax withholding | 86K | $2.82 | $242K | 9.9M |
| 2026-04-18 | Priest Brady Patrick | CEO of Clover Care Services | Tax withholding | 36K | $2.19 | $79K | 2.1M |
| 2026-04-15 | Soares Karen | Chief Legal Officer | Tax withholding | 10K | $2.04 | $21K | 1.6M |
| 2026-04-15 | Wai Conrad | CEO, Counterpart Health | Tax withholding | 23K | $2.04 | $48K | 1.2M |
| 2026-04-15 | Priest Brady Patrick | CEO of Clover Care Services | Tax withholding | 15K | $2.04 | $32K | 2.2M |
| 2026-04-15 | Reynoso Jamie L. | CEO, Medicare Advantage | Tax withholding | 13K | $2.04 | $26K | 2.9M |
| 2026-04-15 | Toy Andrew | Chief Executive Officer | Tax withholding | 61K | $2.04 | $124K | 10.0M |
| 2026-04-15 | THORNTON JOSEPH CLAY | Interim CFO | Tax withholding | 4K | $2.04 | $8K | 1.2M |
| 2026-04-03 | Reynoso Jamie L. | CEO, Medicare Advantage | Tax withholding | 6K | $1.72 | $11K | 2.9M |
| 2026-04-01 | Soares Karen | Chief Legal Officer | Grant | 383K | $0.00 | $0 | 1.6M |
| 2026-04-01 | Wai Conrad | CEO, Counterpart Health | Grant | 268K | $0.00 | $0 | 1.2M |
| 2026-04-01 | Priest Brady Patrick | CEO of Clover Care Services | Grant | 191K | $0.00 | $0 | 2.2M |
| 2026-04-01 | Reynoso Jamie L. | CEO, Medicare Advantage | Grant | 159K | $0.00 | $0 | 2.9M |
| 2026-04-01 | Toy Andrew | Chief Executive Officer | Tax withholding | 310K | $1.76 | $545K | 10.1M |
| 2026-04-01 | Toy Andrew | Chief Executive Officer | Grant | 956K | $0.00 | $0 | 10.4M |
| 2026-03-18 | Reynoso Jamie L. | CEO, Medicare Advantage | Sell | 6K | $1.91 | $11K | 2.7M |
| 2026-03-15 | Soares Karen | General Counsel & Secretary | Tax withholding | 5K | $1.98 | $9K | 1.2M |
| 2026-03-15 | Reynoso Jamie L. | CEO, Medicare Advantage | Tax withholding | 6K | $1.98 | $12K | 2.7M |
| 2026-03-14 | Wai Conrad | CEO, Counterpart Health | Tax withholding | 100K | $1.98 | $198K | 926K |
| 2026-03-14 | Reynoso Jamie L. | CEO, Medicare Advantage | Tax withholding | 9K | $1.98 | $18K | 2.7M |
| 2026-03-04 | Priest Brady Patrick | CEO of Home Care | Sell | 175K | $2.17 | $380K | 2.0M |
| 2026-02-14 | Soares Karen | General Counsel & Secretary | Tax withholding | 6K | $2.02 | $12K | 1.2M |
| 2026-02-08 | Toy Andrew | Chief Executive Officer | Tax withholding | 86K | $2.13 | $183K | 9.4M |
| 2026-01-29 | Kuipers Peter J. | Chief Financial Officer | Tax withholding | 157K | $2.31 | $362K | 5.8M |
| 2026-01-20 | Reynoso Jamie L. | CEO, Medicare Advantage | Sell | 5K | $2.58 | $12K | 2.7M |
| 2026-01-18 | Priest Brady Patrick | CEO of Home Care | Tax withholding | 37K | $2.54 | $94K | 2.2M |
| 2026-01-15 | Toy Andrew | Chief Executive Officer | Tax withholding | 61K | $2.81 | $171K | 9.5M |
| 2026-01-15 | Soares Karen | General Counsel & Secretary | Tax withholding | 12K | $2.81 | $33K | 1.2M |
| 2026-01-15 | Wai Conrad | CEO, Counterpart Health | Tax withholding | 26K | $2.81 | $73K | 1.0M |
| 2026-01-15 | Reynoso Jamie L. | CEO, Medicare Advantage | Tax withholding | 15K | $2.81 | $41K | 2.7M |
| 2026-01-15 | Priest Brady Patrick | CEO of Home Care | Tax withholding | 18K | $2.81 | $51K | 2.2M |
| 2026-01-07 | Reynoso Jamie L. | CEO, Medicare Advantage | Sell | 2K | $2.53 | $5K | 2.8M |
| 2026-01-07 | Garipalli Vivek | n/a | Tax withholding | 1.7M | $2.59 | $4.3M | 1.9M |
Form 4 filings are due within two business days of the trade. Insiders sell for many reasons that say nothing about the company; open-market buys are the rarer, stronger signal.
Planned sales (Form 144)
Newest first. JSON4 Form 144 notices on file for CLOV worth $2.7M at the prices reported; 4 in the last 90 days worth $2.7M. Latest: BRADY PRIEST filed on 2026-08-31 to sell 73,516 shares ($305K) from 2026-08-31.
| Filed | Seller | Shares | Market value | Of outstanding | Sale from | Broker |
|---|---|---|---|---|---|---|
| 2026-08-31 | BRADY PRIESTOfficer | 74K | $305K | 0.017% | 2026-08-31 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-08-07 | BRADY PRIESTOfficer | 442K | $2.1M | 0.101% | 2026-08-07 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-07-20 | KAREN SOARESOfficer | 52K | $239K | 0.012% | 2026-07-20 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-07-17 | JAMIE REYNOSOOfficer | 5K | $21K | 0.001% | 2026-07-17 | Morgan Stanley Smith Barney LLC Executive Financial Services |
13F holders
Tracked managers holding CLOV at their latest 13F. JSON6 of the 30 tracked managers held CLOV at their latest 13F, $61.9M in total at quarter-end prices. Citadel Advisors is the largest at $22.9M (0.0% of its portfolio) as of 2026-06-30. Over the prior quarter 5 added shares and 1 cut.
| Fund | Quarter | Shares | Value | Of portfolio | Change in shares |
|---|---|---|---|---|---|
| Citadel Advisors | 2026-06-30 | 4.4M | $22.9M | 0.00% | +1.0M |
| Renaissance Technologies | 2026-06-30 | 2.8M | $14.7M | 0.02% | -594K |
| D. E. Shaw & Co. | 2026-06-30 | 2.0M | $10.3M | 0.00% | +1.9M |
| Millennium Management | 2026-06-30 | 1.1M | $5.8M | 0.00% | +51K |
| Point72 Asset Management | 2026-06-30 | 1.1M | $5.6M | 0.01% | +567K |
| AQR Capital Management | 2026-06-30 | 488K | $2.6M | 0.00% | +383K |
Only the 30 tracked managers on the funds hub; a 13F reports long positions in US listed stock at quarter end, 45 days late, and says nothing about shorts or positions sold since.
Financials
SEC XBRL, as filed. JSONIn Q2 2026 (quarter ended 2026-06-30) CLOVER HEALTH INVESTMENTS, CORP. /DE reported revenue of $743.2M, up 55.6% from the same quarter a year earlier, and net income of $28.0M (0.05 diluted EPS). In FY 2025 it generated -$66.9M of operating cash flow and spent $18.3M on buybacks.
- Equity
- $376.3M
- Total assets
- $720.3M
Quarterly, last 8 quarters
| Quarter | Period end | Revenue | Net income | Margin | Diluted EPS |
|---|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $743.2M | $28.0M | 3.8% | 0.05 |
| Q1 2026 | 2026-03-31 | $749.2M | $27.3M | 3.6% | 0.05 |
| Q4 2025derived | 2025-12-31 | $487.7M | n/a | n/a | n/a |
| Q3 2025 | 2025-09-30 | $496.6M | -$24.4M | -4.9% | n/a |
| Q2 2025 | 2025-06-30 | $477.6M | -$10.6M | -2.2% | -0.02 |
| Q1 2025 | 2025-03-31 | $462.3M | -$1.3M | -0.3% | 0.00 |
| Q4 2024derived | 2024-12-31 | $337.0M | n/a | n/a | n/a |
| Q3 2024 | 2024-09-30 | $331.0M | -$9.2M | -2.8% | n/a |
Fiscal years, with buybacks and dividends
| Fiscal year | Ends | Revenue | Net income | Operating cash flow | Capex | Buybacks | Dividends |
|---|---|---|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $1.92B | n/a | -$66.9M | $2.0M | $18.3M | n/a |
| FY 2024 | 2024-12-31 | $1.37B | n/a | $34.8M | $1.6M | $1.8M | n/a |
| FY 2023 | 2023-12-31 | $1.26B | n/a | -$144.7M | $584K | $0 | n/a |
| FY 2022 | 2022-12-31 | $1.10B | n/a | -$203.9M | $4.5M | $0 | n/a |
| FY 2021 | 2021-12-31 | $1.47B | n/a | -$282.3M | $723K | $147K | n/a |
Quarters are the three-month figures the company reports; a fourth quarter marked derived is the fiscal year less the three reported quarters, since companies report it only inside the 10-K. Fiscal years are the annual figures. Buybacks are cash paid to repurchase common stock in the year (XBRL PaymentsForRepurchaseOfCommonStock), not authorizations. Balance sheet lines are as of 2026-06-30.
What this page is
CLOVER HEALTH INVESTMENTS, CORP. /DE in the regulatory record
Regulators publish company data in separate files that never sit next to each other: FINRA's twice-monthly short interest, its daily short sale volume, the SEC's fails-to-deliver counts, and each insider's Form 4. A company page pulls every series the site collects for one ticker onto one URL, keyed by the SEC's own ticker list, so the short position, the daily flow, the settlement fails and what insiders are doing can be read together.
Each section has its own history table, a summary sentence built from the rows (last value, change, range with dates) and its own JSON and CSV links. Nothing on the page is written by a model; the sentences change only when the data does. A page exists only for companies with data in at least two series, and every section says when its source last updated.
This page follows CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV), SEC CIK 1801170, listed on Nasdaq, classified by the SEC as hospital & medical service plans. The cross-market tables live on the short interest and insider transactions hubs.
Source and method
- Short interest
- FINRA consolidated short interestTwice a month, about eight business days after settlement. Latest 2026-08-14.JSON and CSV
- Daily short volume
- FINRA Reg SHO daily filesEvery trading day, loaded the following morning. Latest 2026-09-11.JSON and CSV
- Fails to deliver
- SEC fails-to-deliver dataTwice a month, a few weeks after the half month ends. Latest 2026-08-14.JSON and CSV
- Planned sales
- SEC EDGAR Form 144EDGAR read every 30 minutes; a notice is filed on or before the sell order. Latest 2026-08-31.JSON and CSV
- 13F holders
- SEC EDGAR Form 13F-HRQuarterly, filed within 45 days of quarter end; 30 tracked managers. Latest 2026-06-30.JSON and CSV
- Financials
- SEC XBRL company factsRefreshed weekly from the SEC's structured data; values are as filed in the 10-Q and 10-K. Latest 2026-06-30.JSON and CSV
- Insider trades
- SEC EDGAR Form 4EDGAR read every 30 minutes; filings are due two business days after the trade. Latest 2026-08-17.JSON and CSV
- Company record
- EDGAR filing index for CIK 1801170Ticker, name and exchange from the SEC's company list, refreshed weekly.
- Rate limits
- 30 requests a minute without a key, 120 a minute with a key from a free account.
Data checks. Every dataset is checked against its source once a day. This dataset passed the last run, 13 Sep 05:40 UTC.
How to read it
- Read the position against the flow: rising short interest with a high daily short share is new shorting; rising short interest with a normal short share is old shorts holding on.
- Insider buys next to a crowded short are the combination that has historically preceded squeezes; insider sells next to a crowded short are common and mean little.
- Fails to deliver matter relative to the float, not in absolute shares; a million failed shares in a mega cap is noise.
Analysis of what the data shows, not advice. XOOMAR does not recommend buying, selling or holding anything.
Other companies the SEC classifies as hospital & medical service plans
- UNHUNITEDHEALTH GROUP INC
- ALHCAlignment Healthcare, Inc.
- CICigna Group
- HUMHUMANA INC
- ELVElevance Health, Inc.
- MOHMOLINA HEALTHCARE, INC.
- CRWVCoreWeave, Inc.
- UTHRUNITED THERAPEUTICS Corp
- TEAMAtlassian Corp
- CVNACARVANA CO.
- CRWDCrowdStrike Holdings, Inc.
- RCGRENN Fund, Inc.
- APPAppLovin Corp
- SESea Ltd
- VICRVICOR CORP
- GOOGLAlphabet Inc.
- ANETArista Networks, Inc.
- CRMSalesforce, Inc.
- RDDTReddit, Inc.
- CRDOCredo Technology Group Holding Ltd
- NVDANVIDIA CORP
- METAMeta Platforms, Inc.
- STXSeagate Technology Holdings plc
- APPFAPPFOLIO INC
Datasets
Frequently Asked Questions
How much of CLOV is sold short?
What is CLOV's daily short volume?
Does CLOV have fails to deliver?
Are CLOV insiders buying or selling?
Have CLOV insiders filed to sell?
What did CLOV report last quarter?
Which funds hold CLOV?
Data on this page is provided for informational purposes only and is not financial advice. See our editorial policy.